Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$7.97M$7.97Mderivedno prior Q4 2018 on file Net Income$844.97K$844.97Kderivedno prior Q4 2018 on file EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$1,719,399— Operating Cash Flowderived$1,124,451+33.2% Free Cash Flowderived$969,495+20.3% Margins · derivedOperating margin21.6%
Net margin10.6%
ended Nov 30, 2019 · filed Feb 28, 2020 · 90 d after period end